Creative Medical Technology Holdings, Inc. Stock
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.995 USD | -3.94% | -10.72% | +8.35% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 563K | Capitalization | 6.78M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -6M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 12 x |
P/E ratio 2024 * |
-1.11
x | P/E ratio 2025 * |
-1.38
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.33% |
1 day | -3.94% | ||
1 week | -10.72% | ||
Current month | -4.13% | ||
1 month | -6.81% | ||
3 months | +12.65% | ||
6 months | +2.99% | ||
Current year | +8.35% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-05-17 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 21-12-01 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Executive Officer | 63 | 16-05-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 4.995 | -3.94% | 19,042 |
24-04-16 | 5.2 | -0.19% | 4,320 |
24-04-15 | 5.21 | 0.00% | 7,851 |
24-04-12 | 5.21 | -4.67% | 4,124 |
24-04-11 | 5.465 | -2.32% | 6,100 |
Delayed Quote Nasdaq, April 17, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.35% | 7.05M | |
-3.39% | 102B | |
+2.61% | 96.09B | |
-1.02% | 22.05B | |
-18.14% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.89% | 14.01B | |
+1.12% | 13.38B | |
+22.25% | 11.01B |
- Stock Market
- Equities
- CELZ Stock